HCRTR1 and pancreatic neoplasm: Here, the comparison between gemcitabine, Nab-paclitaxel, and OxA treatment on the OX1R-expressing pancreatic cancer cell line, AsPC-1, showed that OxA had a similar impact in terms of cancer cell growth as compared to gemcitabine and Nab-paclitaxel.